Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
385 News Items found
MSK patient receiving chemotherapy
In the Clinic
Discover some of the latest innovations in chemotherapy for breast cancer.
Physician-scientist Omar Abdel-Wahab in his lab.
In the Lab
MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.
Blue cells on a black background
In the Lab
Scientists at Memorial Sloan Kettering have created a model of rectal cancer using human-tumor-derived organoids.
Red blood cells
Finding
A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.
Pediatric oncologist Julia Glade Bender
Q&A
Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.
illustration of the p53 protein binding to a DNA helix
In the Lab
Surprise! It has to do with metabolism.
A micrograph of a cell nucleus
Finding
An MSK study explains how the drug selinexor, which was recently approved to treat multiple myeloma and is being tested in many other tumor types, stops cancer.
Finding
A study from MSK takes a deeper look at some of the causes of secondary leukemia.
a man holding a shield and sword
Finding
This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.
Microscopy image of vancomycin-resistant Enterococcus
In the Lab
MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.